NL-OMON25589
Completed
Not Applicable
The Contribution of the Sympathetic Nervous System to the Anabolic Effect of Estrogen on Bone.
Academic Medical Center0 sites32 target enrollmentTBD
Conditionsosteoporosis, osteoporose
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- osteoporosis, osteoporose
- Sponsor
- Academic Medical Center
- Enrollment
- 32
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
/A
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\. Female sex;
- •2\. Last menstrual cycle 12\-60 months ago.
Exclusion Criteria
- •1\. Contraindications to HRT, beta\-agonist or beta\-antagonist treatment, such as cardiovascular disease, astma, COPD, renal or hepatic insufficiency;
- •2\. Any medication or disease influencing bone turnover;
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
The contribution of the sympathetic nervous system to the anabolic effect of estrogen on bone.osteoporosis1001329610005959NL-OMON36023Academisch Medisch Centrum32
Withdrawn
Phase 4
Sympathetic Nerve Activity in Renal FailureChronic Kidney DiseaseHypertensionNCT00892892University of Erlangen-Nürnberg Medical School
Withdrawn
Not Applicable
Sympathetic Innervation of the Heart and Cardiac Resynchronization Therapy(CRT)Sympathetic InnervationChronic Heart FailureNCT00567645University Medical Center Groningen
Completed
Not Applicable
Association between sympathetic nerve activation by exercise and serum level of fatty acid binding protein 4JPRN-UMIN000019015Gunma University Graduate School of Medicine Department of Cardiovascular Medicine40
Completed
Not Applicable
Cardiac sympathetic nervous system function and activity as a predictor for appropriate ICD therapy in patients with chronic heart failureheart failure and fatal arrhytmiassudden cardiac death10007521NL-OMON33730Academisch Medisch Centrum300